Evaluates cytotoxicity of synthesized 4-arylpyridin-2-one derivatives against BT474 breast cancer cells, suggesting new treatment options.
A novel approach was proposed to the synthesis of 4‐arylpyridin‐2‐one derivatives, including ones annulated at the N(1)‐C(6) positions with an isoquinoline moiety (2‐aryl‐6,7‐dihydro‐4 H ‐pyrido[2,1‐ a ]isoquinolin‐4‐ones). The method is based on the reaction of N ‐(4‐oxo‐2‐aryl‐3,4,6,7‐tetrahydro‐2 H ‐pyrido[2,1‐ a ]isoquinolin‐3‐yl)benzamides with bases in DMSO. At room temperature, this reaction leads to the elimination of a benzamide molecule, while heating induces cleavage of the N(5)─C(6) bond, providing a route to 4‐arylpyridin‐2‐one derivatives. Cytotoxic activity of the synthesized compounds was evaluated against the BT474 breast cancer cell line.
No takes yet. Share an insight, caveat, or question.
Churilova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: